Liver cell therapy company Promethera grows Asian investor base with D round

Belgian company Promethera added new Japanese and Korean investors in its series D round Monday, as part of its focus on growing its Asia network to leverage the "openness" to stem cell therapies in the region.

Promethera Biosciences S.A. (Mont-Saint-Guibert, Belgium) raised €29.7 million

Read the full 431 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE